Genetic Testing for Personalized medicine and Limitations of the Current Medical Practice in Public Health

Ki Anthony Lui, Martin C.S. Wong

Research output: Book/ReportBook


According to a press release in May 2020, HKSAR Government will invest $1.2 billion to
establish strategic plans for the development of genomic medicine in Hong Kong. The seven
major goals have been set to improve genetic and genomic services, to train professionals in
genomic medicine, to engage public involvement, to enhance the laboratory network, to establish a biobank network, to increase the regulations in the use of genetic information and to
promote the proper use of genetic testing. HKSAR has realised the importance of using
genomic technology to perform personalised medicine can drive the health care system forward
with potential positive impacts.
The DNA sequence of the entire human genome had been determined in 2003 (Moraes &
Góes, 2016). Subsequent to the first human genome project, genome sequencing of more than
10,000 vertebrate species, plants and even various microorganisms have been performed successfully (Koepfli et al., 2015; Land et al., 2015; Paajanen et al., 2019). With the information of
all these DNA sequences, scientists have spent decades to investigate the gene functions in the
genomes. Now, scientists are able to link gene mutations with many diseases that would allow
health care professionals to provide personalised medicine in future. This chapter will discuss
the rationale and the implementation of personalised medicine, the economic and social impacts, as well as the potential problems of these newer initiatives on the community and in
public health medicine.
Original languageEnglish
Number of pages104
Publication statusPublished - 2021


Dive into the research topics of 'Genetic Testing for Personalized medicine and Limitations of the Current Medical Practice in Public Health'. Together they form a unique fingerprint.

Cite this